This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of pharmaceutical agents. Its unique structure, featuring a benzyl group and a difluoromethylene moiety, makes it a valuable intermediate in the synthesis of bioactive molecules. It is often employed in the design of compounds targeting neurological disorders, such as depression, anxiety, and neurodegenerative diseases, due to its ability to modulate neurotransmitter systems. Additionally, its fluorine-containing structure enhances metabolic stability and bioavailability, making it a key component in the creation of drug candidates with improved pharmacokinetic properties. Researchers also explore its potential in developing enzyme inhibitors and receptor modulators for therapeutic applications.